Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

USPTO grants patent protection for AbSorber cross match-test

The US Patent and Trademark Office (USPTO) has granted patent protection to AbSorber's cross match-test - Xm-One.

Xm-One test can detect antibodies against the endothelial cells that line the inside of blood vessels.

The endothelial cells are the first point of contact between the transplanted organ and the recipient’s immune system.

The company said Xm-One has received patents in other regions including the EU, India, Australia and Canada.

Allenex CEO Anders Karlsson said currently they are working in collaboration with laboratories in the US to establish clinical use of the product.